PTK2 and triple-negative breast carcinoma: In fact, we tested MDA-231 triple-negative breast cancer cells with FAK autophosphorylation inhibitor [6, 20, 21] and showed that this FAK inhibitor significantly decreased cancer cell viability and clonogenicity in vitro (not shown).